Prolonged use of Cosentyx, a biologic medication used to treat various inflammatory conditions, may carry certain risks. However, it is important to note that the information provided by the sources you provided does not directly address the specific risks associated with prolonged use of Cosentyx. Instead, the sources offer information about the drug's patent status, its efficacy in treating certain conditions, and its mechanism of action. Therefore, it is necessary to rely on additional sources to obtain a comprehensive understanding of the risks associated with prolonged Cosentyx use.

To assess the risks associated with Cosentyx, it is advisable to consult reputable medical sources such as the prescribing information provided by the drug manufacturer, clinical trials, and studies published in peer-reviewed journals. These sources can provide more detailed and reliable information on the potential risks and side effects associated with prolonged use of Cosentyx.

It is important to note that any medication, including Cosentyx, may carry potential risks and side effects. Common side effects associated with Cosentyx include upper respiratory tract infections, diarrhea, and injection site reactions. Serious side effects may include allergic reactions, infections, and inflammatory bowel disease. Additionally, long-term use of biologic medications like Cosentyx may have an impact on the immune system, potentially increasing the risk of certain infections. However, the specific risks and side effects of prolonged Cosentyx use can vary depending on individual factors and should be discussed with a healthcare professional.

In conclusion, while the sources provided do not directly address the risks associated with prolonged Cosentyx use, it is important to consult reputable medical sources and healthcare professionals to obtain accurate and comprehensive information regarding the potential risks and side effects of this medication.

Sources:
[1] Drug Patent Watch. Cosentyx. Retrieved from: https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] PubMed. Cosentyx: a review of its use in the treatment of ankylosing spondylitis and psoriatic arthritis. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/35146532/
[3] Arthritis Research & Therapy. Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis. Retrieved from: https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-1882-2